BCLSI
OLMA icon

Bain Capital Life Sciences Investors’s Olema Pharmaceuticals OLMA Stock Holding History

Bain Capital Life Sciences Investors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.6M Sell
7,085,249
-387,989
-5% -$5.2M 5.27% 8
2026
Q1 		$111M Sell
7,473,238
-1,035,403
-12% -$23M 10.05% 3
2025
Q4 		$213M Buy
8,508,641
+1,664,687
+24% +$29.6M 16.29% 3
2025
Q3 		$67M Hold
6,843,954
– – 4.45% 5
2025
Q2 		$29.2M Hold
6,843,954
– – 3.65% 9
2025
Q1 		$25.7M Sell
6,843,954
-626,260
-8% -$3.15M 3.81% 8
2024
Q4 		$43.6M Buy
+7,470,214
New +$74.6M 5.12% 7

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bain Capital Life Sciences Investors's OLMA Position: Q2 2026 in Review

Bain Capital Life Sciences Investors reduced its Olema Pharmaceuticals (OLMA) stake by 5.2% in Q2 2026, selling an estimated $5.2M and leaving 7,085,249 shares worth $88.6M. The position accounts for 5.27% of the portfolio, ranked #8.

Bain Capital Life Sciences Investors first reported a position in OLMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $213M in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Bain Capital Life Sciences Investors held 7,085,249 shares of Olema Pharmaceuticals worth $88.6M as of Q2 2026.
  • Bain Capital Life Sciences Investors sold 387,989 Olema Pharmaceuticals shares in Q2 2026, an estimated $5.2M.
  • Olema Pharmaceuticals made up 5.27% of Bain Capital Life Sciences Investors's portfolio in Q2 2026, its #8 holding.
  • Bain Capital Life Sciences Investors first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Bain Capital Life Sciences Investors's Olema Pharmaceuticals position peaked at $213M in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Bain Capital Life Sciences Investors's 13F filing for Q2 2026, filed 14 Aug 2026.